Cameroon

in page functions
[French]
Total population (2016) 23,924,336
Birth cohort (2016) 855,784
Surviving Infants (surviving to 1 year per year, 2016) 797,906
Infant mortality rate (deaths < 1 year per 1000 births, 2015) 57/1000
Child mortality rate (deaths < 5 years per 1000 births, 2015) 88/1000
World Bank Index, IDA (2012) 3.17
Co-financing status (2016) Preparatory transition
No. of districts/territories (2014) 187

Gavi support for Cameroon

Type of support

Approvals

2001-2020 (US$)
(30 Apr 2016)

Commitments

2001-2020 (US$)
(30 Apr 2016)

Disbursements

2000-2016 (US$)
(30 Apr 2016)

% Disbursed

(30 Apr 2016)
2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Cash Support (CASHSUPP) $203,000 $228,000 $203,000 100%
Civil Society Organisation support (CSO) $56,199 N/A
Health system strengthening (HSS 1) $6,964,448 $6,964,448 $6,964,448 100%
HPV Demo (NVS) $492,308 $492,308 $493,787 100%
Immunisation services support (ISS) $7,983,620 $7,983,620 $7,983,620 100%
Injection safety support (INS) $992,844 $992,844 $992,844 100%
IPV (NVS) $1,689,773 $2,653,273 $1,448,504 86%
Measles-Rubella (NVS) $6,782,037 $6,782,037 $6,782,037 100%
Meningitis A - campaign (NVS) $4,324,774 $4,324,774 $4,324,774 100%
Meningitis A - operational costs (OPC) $2,508,980 $2,508,980 $2,508,980 100%
MR - Operational costs (OPC) $5,828,500 $5,828,500 $5,828,500 100%
Penta (NVS) $39,186,849 $39,186,849 $38,927,175 99%
Pneumo (NVS) $70,123,187 $70,123,187 $81,310,591 116%
Rotavirus (NVS) $9,275,257 $9,275,257 $8,462,289 91%
Tetra DTP-HepB (NVS) $9,000,675 $9,000,675 $9,000,675 100%
Vaccine Introduction Grant (VIG) $2,855,500 $2,855,500 $2,755,500 96%
Yellow Fever (NVS) $6,362,304 $6,362,304 $6,516,243 102%
Total $174,574,054 $175,562,554 $184,559,165

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the Gavi Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding

Download data for commitments, approvals & disbursements in XLS format

Cameroon DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2014)

Grade of confidence


N/A
DTP3 - Official country estimates (2014) 87%
M:F sex ratio at birth (2016) 1.03
Household survey: DTP3 coverage for male (2010) 68.10%
Household survey: DTP3 coverage for female (2010) 68.60%
Household survey: Last DTP3 survey (2010) 68%
% districts achieving > 80% DTP3 coverage (2014) 71%
% districts achieving < 50% DTP3 coverage (2014) 1%
MCV WHO/UNICEF estimates (2014) 80%

Breakdown of support

Non-vaccine support Vaccine support
15% 85%
$27,293,090 $157,266,070

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

News and updates relating to Cameroon

23 May 2016

Cameroon cholera campaign

World Humanitarian Summit - Gavi's Fragility and Immunisation Policy

Gavi to review its response to humanitarian emergencies and fragile settings in 2016.

22 February 2016

Gavi item

Meningitis A nearly eliminated in Africa through vaccination

Joint press release first published by WHO and PATH, joint founders of the Meningitis Vaccine Project.

03 December 2015

First use of Gavi Cholera Stockpile - Cameroon 2015

A short film explaining how Gavi came to support a global cholera vaccine stockpile, and showing the impact this has had on the vaccine market and in Cameroon where it was first deployed.

close icon

modal window here